Other
Neoplasm by Morphology
CI-CAN-00000002Explore in graph →
Non-malignant13,319 active trials222 approved drugs2,774 evidence items
- NCIt
- C4741
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000002Explore in graph →
Clinical trials
52,657 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04477967 | Design and Implementation of the Pediatric Liver Transplantation Biobank | recruiting | — | 500 | Children's Hospital of Chongqing Medical UniversityOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT04466189 | Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy | enrolling by invitation | — | 120 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 13, 2020 |
| clinicaltrials |
| NCT04465968 | Efficacy and Safety of CRT, Durvalumab and Surgery for SST(DEEP_OCEAN) | not yet recruiting | Phase 3 | 84 | National Cancer Center Hospital EastOTHER | 0 | Jul 10, 2020 | clinicaltrials |
| NCT04150744 | RFA Plus Carrizumab vs Carrizumab Alone for HCC | recruiting | Phase 2 | 120 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jul 8, 2020 | clinicaltrials |
| NCT02592083 | Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors(PREDIX LumA) | active not recruiting | Phase 2 | 10 | Thomas HatschekOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT04437160 | Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy | recruiting | Phase 2 | 286 | Chinese Academy of Medical SciencesOTHER | 1 | Jun 18, 2020 | clinicaltrials |
| NCT04167696 | Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02(CYCLE-1) | recruiting | Phase 1 | 27 | Celyad Oncology SAINDUSTRY | 2 | Jun 9, 2020 | clinicaltrials |
| NCT04281641 | Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer(PHC-BC) | recruiting | N/A | 94 | Fudan UniversityOTHER | 1 | May 4, 2020 | clinicaltrials |
| NCT04365751 | To Compare the Efficacy of Microwave Ablation and Laparoscopic Hepatectomy for Hepatocellular Carcinoma | recruiting | N/A | 1,134 | Chinese PLA General HospitalOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT04338386 | Detection and Pathogenesis of Novel Protein F | not yet recruiting | — | 100 | Wuhan Asia Heart HospitalOTHER | 0 | Apr 10, 2020 | clinicaltrials |
| NCT04316039 | Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery | recruiting | Phase 2 / Phase 3 | 250 | West China HospitalOTHER | 1 | Mar 20, 2020 | clinicaltrials |
| NCT03474237 | A Prospective Cohort Study for Patients With Adrenal Diseases | enrolling by invitation | — | 1,500 | Seoul National University HospitalOTHER | 1 | Mar 18, 2020 | clinicaltrials |
| NCT04301739 | to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC) | not yet recruiting | Phase 3 | 522 | Shanghai Henlius BiotechINDUSTRY | 0 | Mar 12, 2020 | clinicaltrials |
| NCT03793517 | Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT | recruiting | Phase 2 / Phase 3 | 55 | Peking University People's HospitalOTHER | 1 | Mar 10, 2020 | clinicaltrials |
| NCT04157569 | CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia | recruiting | — | 200 | Navy General Hospital, BeijingOTHER | 1 | Feb 25, 2020 | clinicaltrials |
| NCT04225858 | Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy(ASICS) | not yet recruiting | N/A | 340 | The Netherlands Cancer InstituteOTHER | 0 | Jan 13, 2020 | clinicaltrials |
| NCT04209244 | Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia | recruiting | N/A | 100 | Rigshospitalet, DenmarkOTHER | 1 | Dec 26, 2019 | clinicaltrials |
| NCT04197414 | Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA | recruiting | — | 3,000 | Yonsei UniversityOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT04158856 | Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer(SHERO) | not yet recruiting | Phase 2 | 60 | xuexin heOTHER | 0 | Nov 12, 2019 | clinicaltrials |
| NCT04153734 | Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLC(Evolution) | not yet recruiting | Phase 2 | 21 | Kobe Minimally Invasive Cancer CenterOTHER | 0 | Nov 6, 2019 | clinicaltrials |
| NCT04136886 | Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma(IMRT) | recruiting | Phase 3 | 346 | Sun Yat-sen UniversityOTHER | 1 | Oct 23, 2019 | clinicaltrials |
| NCT02990936 | Prognostic Impact of Tumor Growth Velocity in Head and Neck Squamous Cell Carcinoma Treated by Radio(Chemo)Therapy(TGV-PI) | not yet recruiting | — | 120 | Centre Hospitalier Universitaire UCLouvain NamurOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT04099134 | PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma(PaCaReg) | recruiting | — | 5,000 | University of UlmOTHER | 1 | Sep 25, 2019 | clinicaltrials |
| NCT04063527 | Phase III Trial of Stage I Ovarian Cancer After Surgery | recruiting | Phase 3 | 360 | Japanese Gynecologic Oncology GroupOTHER | 2 | Aug 30, 2019 | clinicaltrials |
| NCT03815279 | A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM)(iStopMM) | enrolling by invitation | Phase 2 | 80 | Landspitali University HospitalOTHER | 1 | Aug 16, 2019 | clinicaltrials |
| NCT04025450 | Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients | recruiting | Phase 1 / Phase 2 | 50 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Jul 19, 2019 | clinicaltrials |
| NCT03980002 | A Prospective Multicenter Phase 2 Study of FCR/BR Alternating With Ibrutinib in Treatment-naive Patients With CLL(BDHCLL001) | recruiting | Phase 2 | 50 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Jun 10, 2019 | clinicaltrials |
| NCT03966443 | Fluciclovine PET/CT in Multiple Myeloma Patients(FLUCIPET) | recruiting | — | 10 | Oslo University HospitalOTHER | 1 | May 30, 2019 | clinicaltrials |
| NCT03196414 | Study of T Cells Targeting CD138/BCMA/CD19/More Antigens (CART-138/BCMA/19/More) for Chemotherapy Refractory and Relapsed Multiple Myeloma | recruiting | Phase 1 / Phase 2 | 10 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | May 2, 2019 | clinicaltrials |
| NCT03857737 | Endoscopic Submucosal Dissection Versus Surgery in the Treatment of Early Gastric Cancer | not yet recruiting | N/A | 300 | Peking University Third HospitalOTHER | 1 | Feb 28, 2019 | clinicaltrials |
| NCT03698721 | Urothelium Tissue Engineering Using Biopsies From Transurethral Resection of Prostate(IMOPU) | not yet recruiting | — | 365 | Central Hospital, Nancy, FranceOTHER | 0 | Oct 9, 2018 | clinicaltrials |
| NCT03686709 | Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment | recruiting | N/A | 20 | University of TennesseeOTHER | 1 | Sep 27, 2018 | clinicaltrials |
| NCT03647072 | PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy | recruiting | Phase 3 | 60 | Sherief Abd-ElsalamOTHER | 1 | Aug 27, 2018 | clinicaltrials |
| NCT03014687 | Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions(POET) | recruiting | Phase 4 | 116 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Aug 15, 2018 | clinicaltrials |
| NCT03562169 | The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd) | recruiting | Phase 3 | 406 | University of LeedsOTHER | 1 | Jun 19, 2018 | clinicaltrials |
| NCT03494296 | A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCL | recruiting | — | 150 | First Affiliated Hospital of Harbin Medical UniversityOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT02870244 | Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes | recruiting | Phase 1 | 18 | Loyola UniversityOTHER | 1 | Mar 12, 2018 | clinicaltrials |
| NCT01688908 | Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC)(ESECC) | active not recruiting | N/A | 33,948 | Peking UniversityOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT03392233 | Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors | recruiting | Phase 2 | 100 | RenJi HospitalOTHER | 1 | Jan 5, 2018 | clinicaltrials |
| NCT03351842 | Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20% | recruiting | Phase 2 | 460 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | Dec 19, 2017 | clinicaltrials |
| NCT03367884 | Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer | not yet recruiting | N/A | 120 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT03313271 | China Lymphoma Patient Registry Study(CLAP) | recruiting | — | 5,000 | Jun ZhuOTHER | 1 | Oct 18, 2017 | clinicaltrials |
| NCT03253536 | Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma(LIVERCARE) | recruiting | — | 100 | Ludwig-Maximilians - University of MunichOTHER | 1 | Aug 18, 2017 | clinicaltrials |
| NCT02482454 | Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma | active not recruiting | Phase 2 / Phase 3 | 50 | The First People's Hospital of ChangzhouOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT03199066 | Non-Hodgkin Lymphoma - Observational Epidemiological and Clinical Study (NiHiL) | recruiting | — | 20,000 | Czech Lymphoma Study GroupOTHER | 1 | Jun 26, 2017 | clinicaltrials |
| NCT03047265 | Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | active not recruiting | Phase 2 | 164 | Sun Yat-sen UniversityOTHER | 1 | Feb 10, 2017 | clinicaltrials |
| NCT03005132 | Integrative Analysis of Human Glioblastoma Multiforme | recruiting | — | 1,000 | Shanghai 10th People's HospitalOTHER | 1 | Dec 29, 2016 | clinicaltrials |
| NCT02892877 | The French National Reference Centre of GTD(French GTDC) | recruiting | — | 25,500 | Hospices Civils de LyonOTHER | 1 | Sep 8, 2016 | clinicaltrials |
| NCT02884375 | Elderly CAncer Patient(ELCAPA) | recruiting | — | 3,000 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Aug 31, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Jul 20, 2020source: clinicaltrials